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LABORATORY AND FIELD EVALUATION OF EFFICACY OF
VECTOBAC@I2AS AGAINST CULEX SITIENS
(DIPTERA: CULICIDAE) LARVAE
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ABSTRACT. Laboratory bioassay studies of the efficacy of VectoBac@l2AS (active ingredient: 1,200 Inter-
national Toxic Units tITUI/mg Bacillus thuringiensis var. israelensis) against field-collected late 3rd/early 4th-
instar larvae of Culex sitrens indicated excellent control potential. A 95Vo lethal concentration (LCnr) value of
1.381 X l0? ITU was calculated, which equated to a dosage of 0.011 litersftra. This dosage represented 1.87o
of the recommended lowest dosage rate for the product. A fietd trial of VectoBac l2AS against late 3rd/early
4th-instar field specimens of Cx. sitiens in floating mesh cylinders was then conducted in salt-marsh pools near
Coomera Marina, southeast Queensland, Australia. At a rate of 0.5 liters/tra, 1007o mortality of Cx. sitiens larvae
was recorded at 24 h posttreatment.
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INTRODUCTION
In Queensland, Australia, Culex sitiens Weide-
mann is an important pest species that utilizes in-
tertidal pools as a larval habitat (Lee et al. 1989).
As a consequence of environmental concerns over
temephos usage (Mortimer and Chapman 1995,
Brown et al. 1996), control personnel have been
evaluating alternate larvicides for the elimination of
this mosquito.
Foreign evaluations of various formulations of s-
methoprene (Sawby et al. 1992l. Ross et al. 1994a,
1994b) and Bacillus thuringiensis var. israelensis
(B.t t) (Margalit and Dean 1985, Gharib and Hil-
senhoff 1988, Lee et al. 1996) have shown that
these products can control mosquitoes with mini-
mal environmental impact. Unfortunately, recent
evaluations of s-methoprene against Australian
mosquitoes (Ritchie et al. 1997), have shown that
Cx. sitiens tolerates extremely high levels of this
product. A 99Vo lethal concentration (LCnn) value
of 18 ppb s-methoprene was calculated for Cx. sr-
tiens. T\is suggests that at the label rate, s-metho-
prene treatments will fail from March through May
when C-r. sitiens is most abundant in salt-marsh
habitats in southeastern Queensland. Accordingly,
we conducted laboratory and field investigations
into the efficacy of a liquid formulation of B.t.i. for
use against Cx. sitiens larvae.
MATERIALS AND METHODS
Laboratory bioassays: Laboratory bioassays,
based on standard methods for testing of larval sus-
ceptibility (World Health Organization 1981), were
I Queensland Institute of Medical Research, Royal Bris-
bane Hospital P O., Brisbane, Queensland 4029 Australia.
'  Gold Coast City Council, P O. Box 5042, Gold Coast
MC, Queensland 9729 Australia.3 Hoechst Schering AgrEvo Pty. Ltd., Environmental
Health Division, Level 1, 27 Sirius Road, Lane Cove,
New South Wales 2066 Australia.
used to determine the effectiveness of Vecto-
Bac@l2AS (active ingredient: 1,200 International
Toxic Units [ITU]/mg B.t.i. [1.279 x 10'ITU/liter],
with a label rate of 0.6-I.2 liters/ha, Hoechst Sch-
ering AgrEvo fty. Ltd., Pennant Hills, New South
Wales, Australia) against field-collected Cx. sitiens
larvae. The larvae were collected from salt-marsh
pools near Coomera Marina (27"54'5, 153'17'E).
Habitat water was also collected for experimental
and maintenance purposes. In the assays, larvae
were exposed to serial dilutions of VectoBac 12AS
in filtered (l0O-pm-mesh net) habitat water. Five
replicates each of 2O late 3rilearly 4th-instar larvae
were introduced into 250-ml glass beakers contain-
ing 200 ml of test concentration. Five control beak-
ers holding 20 test larvae each in habitat water
without pesticide were used for each bioassay. To
minimize variability due to nutritional and meta-
bolic condition, larvae were not fed for 24 h pior
to or during testing. Initially, a number of range-
finding bioassays with widely spread exposure con-
centrations were conducted. Based on these tests, a
narrow range of concentrations that straddled the
effective range were conducted. The numbers sur-
viving were counted at 24 h. Death or the lack of
reaction to gentle prodding with a glass pipette was
the measured mortality. The assays were conducted
at25"C under a light:dark cycle of 12:12 hours.
Field bioassays.' The laboratory bioassay data
indicated that effective Cx. sitiens control could be
achieved at an application rate of 0.5 liters/ha. Ac-
cordingly, the bioefficacy of this dosage was eval-
uated in the field in conjunction with the currently
utilized dosage rate of 1.0 liter/ha. The field trial
was conducted by exposing field-collected late 3rd./
early 4th-instar Cx. sitiens larvae to 0.5 liter/ha
concentrations of VectoBac 12AS in small (ca. 5-
m' , 5-10-cm-deep) salt-marsh pools near Coomera
Marina. The formulation was applied using a pres-
surized knapsack sprayer (Stainless Steel Tanks and
Pressure Vessels Pty. Ltd., Melbourne, Victoria,
Australia). Assessment of efficacy was made by the
use of floating 2O-cm-deep X l0o-cm-diam, open-
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Table 1' Tw"nty-!u.holl!.o!tt unalyses of vectoBac@ l2AS toxicity to 3rd-instar culex sitiens.l
Abiotic characteristics (mean + SD)
LCrut
(liters/ha)
LC,,'
(liters/ha)
lntercept
(SE)
Turbi-
dity
(NTUs)
Dissolved
oxygen
(mgAiter)
Temp-
era-
ture
cc)
Slope
(SE) P3 pH
Salini-
ty
(ppk)
o.oo77(o.oo74,0.0081) 0 .011(0.010,0.0120) 20.125 0.983(2.2sr)42.485(4.7s9) 7 .38(10.13) 3 .86/ + n  ? r 2525
'LC.,,, median lethal concentration; LCr., 95Vo lethal concentration; NTUs, nepholometric turbidity units.
' Values in parentheses are the 95go lower and uptrrr confidence limits.3 P refers to the probability conesponding to maximum likelihood chi-square statistic for goodness of fit of the model.
topped, 280-pm mesh cylinders. Six intertidal salt-
marsh pools were selected for study, and one cyl-
inder containing 100 Cx. sitiens was placed in each
pool 2 h prior to treatment. Of these, 3 pools were
selected as untreated controls and 3 pools received
a 0.5 liter/tra treatment. Control pools were located
upwind of those treated with B.t i. The numbers
surviving were counted at 24 h, and percentage
mortality was calculated. Because abiotic parame-
ters of water can affect the toxicity of a substance
(Cooney 1995), temperature, pH, dissolved oxygen
(DO), salinity, and turbidity were recorded prior to
treatment and at 24 h using a portable field labo-
ratory (Horiba Ltd., Kyoto, Japan).
Analysis of data-laboratory bioassay.. A probit
model was used to analyze Cx. sitiens mortality as
a function of B.t.i. concentration. The SPSS for
Windows version 7.0 PROBIT procedure (Norusis
1990) was used for this analysis. The median lethal
concentration (LCrn) and 95Vo lethal concentration
(LCnr) and associated 95Vo confidence intervals
were calculated.
Analysis of data-field bioassay: Repeated mea-
sures of analysis of variance models were used to
test the significance of pre- to postapplication
changes in each of the abiotic water variables. Pois-
son regression models were then used to consider
whether the mean postapplication larval count dif-
fered by treatment group for any of the abiotic wa-
ter variables. Repeated measures analysis of vari-
ance models were used to model postapplication
larval counts by 0.5 liter/ha dose of Vecto-
Bac@l2AS, allowing estimates of effect to be ad-
justed for any changes in the abiotic water vari-
ables.
RESULTS AND DISCUSSION
From this study it is evident that C. sitiens is
extremely sensitive to B.t.i. In the laboratory bio-
assay study, an LCe5 value of 0.011 liters/ha was
calculated, which represented l.8Vo of the low label
rate for VectoBac 12AS in Australia (Table 1). This
sensitivity may have been augmented in the labo-
ratory bioassays by a number of factors. The ab-
sence of food in the test containers, the 24-h star-
vation period prior to testing, and the absence of
particulate matter (turbidity of 0 nepholometric tur-
bidity units [NTUs]) other than VecroBac 12AS,
which was the only available material during test-
ing, may all have contributed to this result.
Consequently, in the field Cr. sitiens suffered
l0o7o mortality at both 0.5- and 1.0-liters/ha con-
centrations of VectoBac 12AS. No statistical evi-
dence was found to suggest that posttreatment lar-
val counts were associated with any of the environ-
mental variables (P > 0.115). These results are en-
couraging, as they mean an effective alternative to
temephos and s-methoprene is available for treat-
ment of Cx. sitiens larvae, given appropriate for-
mulation.
During the field study, significant posttreatment
changes in turbidity (P < 0.013), temperature (P {
0.001), salinity (P < 0.001), and depth (P < 0.001)
were recorded. Changes in DO (P < 0.055) and pH
(P < 0.091) were not statistically significant. No
statistical evidence was found to suggest that these
changes were associated with the VectoBac l2AS
treatments (P > 0.190) (Table 2).
From October through February in southeastern
Queensland, Aedes vigilax (Skuse) is the predomi-
Table 2. Abiotic water characteristics of salt-marsh pools 24 h after treatment with VectoBac@ l2AS.r
Mean (+SD) abiotic water characteristics in control and treatment pools
EFC
Applicationrate (ITU/ha)
Turbidity Dissolved oxygen Temperature Salinity
pH (NTUs) (mg/liter) CC) (ppk)
Control
O.5 liters/ha
1.0 liters/ha
P
0
0.64 x
1.28 x
9.3  (+0 .5)
9 .2  (+0 .3)
9.4 (+O.2)
0.355
35 (+6)
57 (+18)
s l  ( t l l )
0.285
3.zz 1+6.99,
3.77 (+1. t2)
4.2s 1+9.961
0.849
10e
10,
32.9 (-O.2) 27.t 1+4.51
33.7 (+0.8) 25.O (+3.9)
34.7 (+o.4) 27.2 (tr. ' )
0.063r 0.697
rEFC : estimated field concentration; ITU, international toxic units; NTUs. nepholometric turbidity units.
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nant salt-marsh mosquito requiring control. Culex
sitiens then becomes the major problem from
March through May. Accordingly, given suitable
formulations of B.t.i., a program in which rotation
of s-methoprene followed by B.t.i. from March on-
wards when Cx. sitiens are most plentiful would
seem a sensible option. Also, in terms of acute tox-
icity, Vectobac 12AS has been proven safe for use
with cohabiting shrimps (Leander tenuicornis Say)
and Pacific blue-eye (Pseudomugil signifer Kner)
fish (Brown et al. L996, Brown et al. submitted).
Accordingly, we believe the calibration of land-
based and air-borne ultra-low volume equipment at
0.5 liters/ha is sufficient for applications against Cr.
sitiens larvae in salt-marsh pools in southeastern
Australia. This still leaves a safety margin of 45
times the LCn, to guard against uneven applications.
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